Cost of proton therapy for prostate cancer: without insurance, on Medicare, and why coverage is denied

Proton therapy cost without insurance

The only nationally comparable self-pay numbers come from the centers' own posted charges. A 2021 survey of the 36 proton centers then operating in the United States found that 28 posted a chargemaster and 20 listed a proton delivery charge. The median list price for one session was $4,707 for simple delivery without compensation, $4,712 for simple delivery with compensation, $5,904 for intermediate delivery, and $6,690 for complex delivery, with the most expensive center charging 5 to 10 times the cheapest for the same code.

Multiplying the complex-delivery median by the schedules a prostate patient is likely to be quoted gives $133,800 for 20 sessions, $187,320 for 28, and $260,910 for 39, before simulation, planning, devices, and physician fees. Those are list prices, not what anyone typically pays, but they are the figures a self-pay patient will be quoted first and the figures a denial letter leaves you exposed to.

Two proton centers state their own ranges publicly. The Oklahoma Proton Center describes a course as $25,000 to more than $100,000 depending on the schedule and the payer, with courses of 5 to 44 treatments, and notes that it is required by law to provide a Good Faith Estimate. The Maryland Proton Treatment Center describes a cost-neutral model priced against conventional radiation, self-pay options, and payment plans. Ask any center for its self-pay rate per session, its Good Faith Estimate for the whole course, and whether a cost-neutral rate is available to a patient paying directly.

What one session costs on Medicare in 2026

Medicare pays a hospital outpatient department $1,276.81 for one proton delivery session in 2026 under payment group 5625, regardless of which of the four delivery codes is billed. The Procedure Price Lookup shows the same facility figure, $1,276, and a patient share of about $255 after the Part B deductible; the tool does not publish the physician fee for proton delivery, which is billed on top. At that rate a 20-session course is $25,536.20 in facility payments with $5,107.24 owed, a 28-session course is $35,750.68 with $7,150.14 owed, and a 39-session course is $49,795.59 with $9,959.12 owed, in each case before Medigap and before the one-time planning and physician lines.

Older figures still circulate in search results and are worth recognizing. The $32,000 number that appears in many articles is the median Medicare reimbursement for a proton course in 2008 and 2009, $32,428, against $18,575 for IMRT in the same study. A SEER-Medicare analysis covering 2004 to 2011 put the median cost of a proton course at $54,706, IMRT at $37,090, SBRT at $27,145, and brachytherapy at $17,183. In employer-plan claims from 2008 to 2015, expressed in 2015 dollars, a proton course cost the payer $115,501 with $2,269 out of pocket, against $59,012 and $1,714 for IMRT. None of those are 2026 amounts, but they explain the numbers you will find.

Does Medicare cover proton therapy? Yes, when the contractor's criteria are documented

Yes, Original Medicare Part B covers proton beam therapy for prostate cancer, but through a local coverage determination rather than a national one. There is no national coverage determination for proton therapy, so the Medicare administrative contractor for your region sets the criteria. The contractor policy covering prostate cancer requires the treating physician to document selection criteria based on NCCN guidance and to document that the patient was informed of the range of therapy choices, and it treats enrollment in a clinical trial or a registry favorably. The proton center handles this documentation; ask it to confirm in writing that the file meets the policy before simulation.

The professional society model policy that many payers reference places prostate cancer in a coverage-with-evidence-development group, which means coverage tied to an IRB-approved clinical trial or a multi-institutional registry. That is why proton centers routinely ask prostate patients to enroll in a registry, and why that enrollment appears on approval letters. Under Original Medicare the patient's share is the $283 Part B deductible for 2026 and then 20 percent of the approved amount, which Medigap plans A, B, C, D, F, G, M, and N pay in full.

A Medicare Advantage plan applies its own prior-authorization rules and its own copays, and a plan that runs as an HMO may limit the network to centers it contracts with. From 2026 a Medicare Advantage plan must decide a standard prior-authorization request within 7 calendar days and an expedited one within 72 hours, and must give a specific reason for a denial, which is the reason you will need for the appeal.

Why commercial coverage is denied

Commercial denials for proton therapy in prostate cancer come from the plan's written medical policy, and the policies fall into three groups. The first classifies proton therapy for clinically localized prostate cancer as investigational, which is a coverage classification meaning the plan's evidence standard has not been met, not a statement about the quality of any center or any patient's care. The second treats proton therapy and IMRT as clinically equivalent for localized prostate cancer and decides medical necessity under the plan's own terms, which in practice often means paying the IMRT rate or requiring a reason IMRT cannot be used. The third covers it when the policy's criteria are met, subject to prior authorization.

Blue Cross Blue Shield is not one insurer. It is a federation of more than 30 independent plans, each with its own charged-particle radiotherapy policy, and the table shows how differently they read the same question. Michigan's policy treats proton therapy as established when its criteria are met and warns that prior authorization may be required. Vermont's February 2026 policy and Kansas's policy call it investigational for clinically localized prostate cancer. Tennessee's policy, reviewed June 18, 2026, calls it investigational except in the specific circumstances it lists. Your plan's own policy, not the national name on the card, decides.

The denial letter itself will name one of a short list of reasons: the policy classification, a prior authorization that was never obtained or does not match the technique billed, missing trial or registry enrollment, or missing documentation that the criteria were met. Each of those has a different fix, which is why the first step after a denial is to get the specific reason in writing and the policy number it relies on.

What a Blue Cross-type policy asks for before it pays

Every commercial policy in the table above lists documents, and the same set recurs. The proton center's authorization team assembles most of it, but you can ask for each piece by name and confirm it was sent before the first session, because a denial issued after treatment starts leaves you holding the list price. The table lists what each item is and who produces it.

If the plan denies, the sequence is fixed by the plan documents and federal rules: a peer-to-peer review between the radiation oncologist and the plan's physician reviewer, then a written internal appeal that answers the specific denial reason, then an external review by an independent reviewer once internal appeals are exhausted. Proton centers run this process daily; the Maryland Proton Treatment Center, for example, states that appeals follow a denial as a matter of course. Ask the center for its appeal success record with your plan, and ask what you will owe if the appeal fails.

What cost-neutral proton pricing means

Several proton centers offer to bill a proton course at the rate the payer would have paid for IMRT, which is what the Maryland Proton Treatment Center calls its cost-neutral model. The employer-claims analysis noted the same arrangement at some institutions. It is a pricing agreement between the center and the payer, not a coverage decision: a plan whose policy calls proton therapy investigational can still deny the claim even if the center has agreed to the IMRT rate, and a plan that covers it can still apply its full deductible and coinsurance to whatever rate is billed.

Ask three things in writing. Does cost-neutral apply to the facility charge only or to the physician fees as well? Does it apply to a self-pay patient, and at which IMRT reference rate? And if the plan denies anyway, what does the center bill the patient, the cost-neutral rate or the list price?

Get the Good Faith Estimate and ask these questions

If you are uninsured or paying yourself, the center must give you a written Good Faith Estimate before treatment, listing every expected charge with its code and the provider who will bill it: simulation, planning, devices, each delivery session, image guidance, and the physician's management visits. It is due within 1 business day of scheduling if the course starts 3 to 9 business days out, within 3 business days if it starts 10 or more days out or if you ask for it, and a final bill $400 or more above the estimate can be disputed. The estimate rule does not apply to Medicare or Medicare Advantage patients, whose amounts are set by the schedules above.

Proton centers are few, so many patients travel. Travel, lodging, and time away from work are not covered by Medicare and are rarely covered by commercial plans, and a 20- to 39-session course means four to eight weeks near the center. Ask whether the center runs a lodging program, what it costs, and whether any of it is billed through the estimate.

What this page will not tell you

This page does not say whether proton therapy is a better or worse treatment than any other radiation technique or than surgery, and it does not describe outcomes or side effects. Those are clinical questions for a radiation oncologist and, where surgery is also being considered, a urologist. The only comparisons above are payment comparisons drawn from the same billing schedules and the same studies, presented so you can recognize the numbers you will encounter.

Modern Prostate Institute does not operate a proton center and has no financial relationship with any radiation facility. Every figure is national and dated, list prices change whenever a center updates its file, and Medicare's rate is adjusted for local wages. Confirm the local figure with the center that will bill you and the policy language with the plan that will pay.